Calendar Pieris Pharmaceuticals, Inc.

Equities

PIRS

US7207951036

Delayed Nasdaq 01:15:52 2024-03-28 pm EDT 5-day change 1st Jan Change
0.185 USD -4.49% Intraday chart for Pieris Pharmaceuticals, Inc. -6.05% +3.19%

Chart calendar Pieris Pharmaceuticals, Inc.

321f0289bb426d4ca63df90b.977qE7NFtrX9daEKwkxHnMTUu5vpq1UzrZS0ZsijQAE.h5OuJ4os3d67Kup_gCMo2vyw4u_cxyBb6_L-NZ3nBDaYzJpGgnzXzJAzyg~959211e7a7f657c1a080b25d0143c421

Upcoming events on Pieris Pharmaceuticals, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)

Past events on Pieris Pharmaceuticals, Inc.

2024-03-26 Q4 2023 Earnings Release (Projected)
2023-06-21 08:00 am Annual General Meeting
2023-06-09 10:00 am Jefferies Global Healthcare Conference
2023-05-10 08:00 am Q1 2023 Earnings Call
2023-05-10 07:00 am Q1 2023 Earnings Release
2023-04-17 01:30 pm American Association for Cancer Research Meeting
2023-03-29 08:00 am Q4 2022 Earnings Call
2023-03-29 07:00 am Q4 2022 Earnings Release
2022-12-01 12:10 pm Evercore ISI HealthCONx Conference
2022-11-02 08:00 am Q3 2022 Earnings Call
2022-11-02 07:00 am Q3 2022 Earnings Release
2022-09-14 12:30 pm H.C. Wainwright Global Investment Conference
2022-09-06 02:30 am European Respiratory Society International Congress
2022-08-04 08:00 am Interim 2022 Earnings Call
2022-08-04 07:00 am Interim 2022 Earnings Release
2022-06-22 08:00 am Annual General Meeting
2022-06-08 08:00 am Jefferies Healthcare Conference
2022-05-11 08:00 am Q1 2022 Earnings Call
2022-05-11 07:00 am Q1 2022 Earnings Release
2022-03-01 08:00 am FY 2022 Earnings Call

Annual results

Fiscal PeriodDecember 2018 2019 2020 2021 2022 2023
Net sales
Million USD
Released
Forecast
Spread
29,1
31,5
-7.57%
46,3
29,1
59.03%
29,2
30,2
-3.12%
31,4
25,4
23.49%
25,9
26,6
-2.5%

32,0

EBITDA
Released
Forecast
Spread
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-
0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
-30,8
-27,6
-11.76%
-27,2
-48,4
43.89%
-33,9
-35,7
5.08%
-51,8
-61,0
14.96%
-43,5
-43,2
-0.52%

-36,9

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-27,1
-23,4
-15.67%
-25,5
-47,0
45.81%
-37,1
-36,5
-1.55%
-45,7
-62,7
27.05%
0,00
0,00
-

0,00

Net income
Million USD
Released
Forecast
Spread
-26,8
-23,4
-14.34%
-28,3
-47,0
39.79%
-37,2
-36,9
-1%
-45,7
-55,7
17.87%
-33,3
-34,8
4.39%

-28,9

EPS
USD
Released
Forecast
Spread
-0,50
-0,44
-13.64%
-0,56
-0,76
26.32%
-0,68
-0,68
0%
-0,71
-0,88
19.32%
-0,45
-0,47
4.26%

-0,35

Announcement Date18/03/1912/03/2031/03/2101/03/2229/03/23-

Quarterly results

Fiscal PeriodDecember 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD
Released
Forecast
Spread
4,06
5,32
-23.7%
8,44
2,45
244.02%
11,0
11,3
-2.8%
3,70
3,24
14.07%
5,37
4,51
19.04%
5,85
6,51
-10.21%
1,94
3,50
-44.69%
20,1
4,02
399%
19,5
7,74
152.07%

2,24


2,24


2,24


1,07


1,07

EBIT
Million USD
Released
Forecast
Spread
-19,0
-19,0
-0.19%
-11,0
-20,1
45.38%
-7,46
-9,11
18.18%
-12,3
-15,5
20.6%
-12,2
-14,0
13.09%
-11,5
-11,3
-2%
-15,5
-14,2
-9.23%
2,06
-13,6
115.17%
-11,8
-11,4
-3.9%

-12,1













Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-16,5
-15,5
-7.03%
-9,53
-21,9
56.47%
-5,10
-2,60
-96.19%



-9,74
-14,4
32.39%



-13,2
-14,2
7.16%
3,98
-14,5
127.42%


















Net income
Million USD
Released
Forecast
Spread
-16,5
-15,3
-8.12%
-9,53
-19,5
51.09%
-5,10
-8,21
37.85%
-10,3
-14,6
29.35%
-9,74
-12,0
18.62%
-8,10
-9,63
15.88%
-13,2
-14,2
7.16%
3,98
-11,7
133.93%
-10,8
-9,44
-13.89%

-10,2













EPS
USD
Released
Forecast
Spread
-0,24
-0,24
1.37%
-0,13
-0,30
56.67%
-0,07
-0,12
39.13%
-0,14
-0,20
30%
-0,13
-0,13
0%
-0,11
-0,13
15.38%
-0,18
-0,19
5.26%
0,05
-0,16
131.25%
-0,11
-0,11
0%

-0,12


-0,06


-0,03


-0,05


-0,06

Announcement Date02/11/2101/03/2211/05/2204/08/2202/11/2229/03/2311/05/2310/08/2314/11/23-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise